Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing new technologies: patient-device interactions and deposition.

Gerald C Smaldone1

  • 1Pulmonary/Critical Care, Health Sciences Center, T-17, 040, State University of New York at Stony Brook, Stony Brook NY 11794-8172, USA. gerald.smaldone@stonybrook.edu

Respiratory Care
|August 27, 2005
PubMed
Summary

Advances in aerosol therapy technology improve dose control and lung targeting. Sophisticated in vitro testing predicts in vivo deposition, enhancing clinical aerosol delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jet Nebulization During Mechanical Ventilation: Mass Balance Analysis.

Respiratory care·2025
Same author

High-Flow Nasal Aerosol Therapy; Regional Aerosol Deposition and Airway Responsiveness.

Journal of aerosol medicine and pulmonary drug delivery·2024
Same author

Reply to Henry and Tsuda.

Journal of applied physiology (Bethesda, Md. : 1985)·2024
Same author

Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy.

British journal of clinical pharmacology·2024
Same author

External Jet Nebulization and Measured Ventilator Performance.

Respiratory care·2024
Same author

In Vivo Deposition of High-Flow Nasal Aerosols Using Breath-Enhanced Nebulization.

Pharmaceutics·2024

Area of Science:

  • Pulmonary Drug Delivery
  • Aerosol Science and Technology

Background:

  • Clinical aerosol delivery faces challenges with dose variability and regional lung targeting.
  • Technological advancements are crucial for improving the efficacy of aerosol therapies.

Purpose of the Study:

  • To review advancements in aerosol therapy technology.
  • To assess in vitro testing methods for predicting in vivo deposition.
  • To demonstrate improved control of aerosol delivery in vivo.

Main Methods:

  • Review of current and emerging aerosol delivery technologies.
  • Evaluation of in vitro testing techniques for aerosol performance.
  • Analysis of in vivo deposition data for targeted aerosol delivery.

Main Results:

Related Experiment Videos

  • Technological progress offers solutions for dose variability and lung targeting in aerosol therapy.
  • Sophisticated in vitro testing methods are becoming essential for evaluating advanced aerosol devices.
  • Demonstrated control of aerosol delivery in vivo is achievable with new technologies.

Conclusions:

  • Modern aerosol technology can overcome major challenges in clinical aerosol delivery.
  • In vitro testing plays a critical role in predicting and optimizing in vivo performance.
  • Further development and validation of interactive aerosol devices are warranted.